Home / Inspections / 1106647

FDA Inspection 1106647 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006188513

The FDA completed an inspection of Octapharma Plasma, Inc. on July 17, 2019 in Springfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, IL (United States)

Facility

Other inspections at this facility

  • 1198041 (NAI Thu Jan 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1024599 (NAI Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944107 (NAI Mon Sep 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 818220 (NAI Fri Jan 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 716428 (NAI Thu Mar 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources